Tuesday, November 17, 2026
Late edition · Updated as it breaks
Log inSubmit a story

“All the news worth catching.”

PaparazziPaparazzi
How to earnPaparazzi InkBack PageHolder perksLeaderboardAssignmentsContestsLeagueCity
Catcher tip lineCaught a story first? Earn stock tokens →
Sponsored
Premium projects
DEDeFadePAPackedYour project here
PaparazziPaparazzi

All the news worth catching.

Breaking news on tech, crypto, EVs, e-commerce and social the moment it breaks. Written by AI from verified reporting.

SectionsTop storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & world
EarnStart hereSubmit a storyHow to earnLeaderboardContestsCatcher desksTop catchers by reputationAssignmentsCity LeagueNews bountiesCityMy catchesRewards
MarketsLive statsProof of payoutsWhale watchDeep Scan token checksStock fundToken utilityRobinhood Chain launchesRobinhood Chain projectsPremium project pagesPartnersThe Chain Weekly
PaparazziPaparazzi InkPaparazzi Ink top writersThe Back PageSuggest a Back Page storyPaparazzi on TelegramHow it worksFAQProof of workAbout usHow we score trustEditorial policyPrivacy policyCorrectionsRelease notesAdvertiseContact
$PAPA contract · Robinhood Chain
© 2026 Paparazzi

Written by AI from verified reporting. Not financial advice.

  • Home
  • Submit
  • Earn
  • Sign in
Top storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & worldWhales
Tech & AI
Important· 60

Isomorphic Labs pockets $5B to push its AI-designed drugs into human trials

Isomorphic Labs just raised $5 billion in a Series C, co-led by Greenoaks and Sequoia Capital, to move its AI-designed drug candidates toward clinical trials. The DeepMind spinout says its engine has produced positive preclinical results in oncology and immunology — and it's already working with Eli Lilly, Novartis and J&J.

By the Paparazzi desk Caught by @putri.utami56
Early Catcher
November 17, 2026 · 2:50 PM · techcrunch.com · 1 view
Fact boxTrust 65/100 · Developing
What we verified
  • Original source: techcrunch.com.
  • The source published it on Nov 17, 2026 at 2:50 PM.
What we couldn't
  • No second outlet has reported it yet. Treat it as a single-source claim.

Isomorphic Labs has raised $5 billion in a Series C round, funding its push to get drug candidates into clinical trials. Greenoaks and Sequoia Capital co-led, with Andreessen Horowitz joining as a new investor. Every existing backer re-upped too: Alphabet's GV and CapitalG, Thrive Capital, MGX, Temasek and the UK Sovereign AI Fund.

The cash lands roughly six months after the London lab's $2.1 billion Series B in May. Isomorphic says it will spend it on its drug-design engine and on expanding into more types of medicine. The company didn't disclose a valuation this time, though Bloomberg reported earlier this month it was seeking funding at a $50 billion valuation.

Sponsored

The platform runs simulation AI models across multiple areas of chemistry to design drugs, building on DeepMind's AlphaFold protein-folding breakthrough. Isomorphic says the program has delivered positive preclinical results in oncology and immunology. It has already signed deals with pharma heavyweights Eli Lilly, Novartis and Johnson & Johnson.

This is Isomorphic's first raise since founder and CEO Demis Hassabis stepped back from running DeepMind to focus on drug discovery, shifting into a chairman role there. Hassabis and then-DeepMind director John Jumper won the Nobel Prize in chemistry for AlphaFold, which predicts a protein's 3D structure from its genetic sequence alone.

TopicsIsomorphic Labs · DeepMind · Demis Hassabis · Greenoaks · Sequoia Capital · Andreessen Horowitz · Eli Lilly · Novartis

Share

Source: techcrunch.com

Written by AI from verified reporting.

More stories

  • Tech & AI 32 minutes ago · cnbc.com · Caught by @intan.lestari99 · 0 views
    Jensen Huang to Face House Foreign Affairs Panel Dec. 1, Nvidia Lawyer Set for Dec. 2
  • Tech & AI 36 minutes ago · thedefiant.io · 0 views
    AMD Closes Taalas Buy, Betting on Chips Built for One AI Model
  • Tech & AI 1 hour ago · x.com · 1 view
    Google and Amazon to hold 28% of Anthropic combined once it goes public
  • Tech & AI 3 hours ago · breakingthenews.net · 1 view
    Ireland pushes X's Grok to halt data collection
Catcher tip line

Caught a story we missed?

Log in and send it in. If it checks out, it runs with your name on it and you earn stock tokens. The bigger the story, the bigger the reward.

Submit a story
The newsletter

Get the paper in your inbox.

A short digest of the biggest news, plus optional breaking alerts. Free, no account needed.